Sarepta Therapeutics, Inc.
COMBINATION THERAPIES FOR TREATING MUSCULAR DYSTROPHY
Last updated:
Abstract:
The present disclosure relates to methods of treating Duchenne's Muscular Dystrophy by administering an antisense oligonucleotide that induces exon skipping and a non-steroidal anti-inflammatory compound.
Status:
Application
Type:
Utility
Filling date:
28 Sep 2018
Issue date:
13 Aug 2020